Current Drug Safety · 2016 · 24 citations · 14 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDrug InteractionsKidney TransplantationDrug Interactions In TransplantationDrug-disease InteractionsDrug-drug Interaction RiskDrug-drug InteractionsInteraction Risk AssessmentDrug - Drug Interaction DetectionDrug - Drug Interaction ManagementDrug Interaction EpidemiologyDrug-drug Interaction EvaluationKidney Transplant CareRenal Drug InteractionsRenal Drug-drug InteractionsSerious Adverse Drug Reactions
AIM: Renal transplant patients are frequently subject to polypharmacy and drug-drug interactions. However, no previous study has systematically assessed the risk of drug interactions and Adverse Drug Reactions (ADRs) in this population. METHODS: A total of 138 consecutive adult kidney transplant recipients admitted to our hospital between August 2010 and February 2012 were prospectively and systematically assessed by our pharmacovigilance team, within 24 hours of admission, to identify potential drug-drug interactions and probable ADRs. RESULTS: As a consequence of the high number of medications per patient (7.8±0.2 drugs), a considerable number of drugdrug interactions were observed in this population, with an average of 5.6±0.4 drug interactions per patient. Moreover, a significant percentage of admissions (~10%) of kidney transplant patients were related to probable ADRs. Almost all these patients had at least one drug interaction that could have potentially contributed to the probable ADR. Of note, clinically significant (i.e. severe) drug interactions were more frequent among patients with ADRs (29% vs. 15%, p<0.01). Also, patients with ADRs were more likely to have started a medication 30 days before admission (38.5% vs. 10.4%, p < 0.01). Non-immunosuppressive drugs most commonly involved in severe interactions were omeprazole, magnesium sulphate, and statins. The most commonly observed interactions were: tacrolimus and omeprazole, mycophenolate and omeprazole, sirolimus and enalapril, mycophenolate and antivirals, and mycophenolate and magnesium sulphate. CONCLUSION: Drug interactions were extremely frequent among kidney transplant recipients, and responsible for potentially avoidable ADRs. They should be carefully considered when following kidney transplant recipients.
14
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Munir Pirmohamed, Sally James, Shaun Meakin et al. · BMJ · 2004 · 3.2K citations · Full text
Adverse drug reactions: definitions, diagnosis, and management
I. Ralph Edwards, Jeffrey K Aronson · The Lancet · 2000 · 3K citations
Drug related admissions to medical wards: a population based survey.
Jesper Hallas, LF Gram, Ellen Grodum et al. · British Journal of Clinical Pharmacology · 1992 · 203 citations · Full text
Hypertension After Kidney Transplant
Mahendra Mangray, John P. Vella · American Journal of Kidney Diseases · 2011 · 162 citations
Medicine, Nephrology, Surgery +12